In PDA, pancreatic cancer cells activate PSCs through various signaling (MAPK, PI3k/Akt, and JAK-STAT) pathways, inflammatory cytokines and reactive oxygen species that induce aberrant activation of PSCs [8]. This evidence concerns the gene SOAT1 and Patent ductus arteriosus.